The stock will trade on the merger arbitrage spread between the current price and the $102.50 cash consideration plus CVR upside. Monitor the definitive proxy filing for the special meeting date and any stockholder litigation that could delay the close. The guidance suspension removes near-term fundamental catalysts.
Price Chart
Executive Summary
Lantheus reported Q2 2026 revenue of $388.2M (+2.7% YoY) and GAAP EPS of $1.11, roughly in line with the $1.11 Street consensus. However, the headline event is the previously announced definitive merger agreement with Curium for up to $114.50/share ($8.0B total value), which has led the company to suspend its FY2026 guidance. The standalone Q2 results were mixed with PYLARIFY declining 4.1% YoY, but the acquisition premium dominates the stock's direction.
Key Financial Metrics
Key Facts
- Worldwide revenue of $388.2M in Q2 2026, up 2.7% YoY
- GAAP diluted EPS of $1.11 vs $1.12 in Q2 2025; adjusted diluted EPS of $1.55 vs $1.57
- PYLARIFY sales declined 4.1% YoY to $240.4M; DEFINITY grew 5.2% to $88.3M; Neuraceq contributed $39.6M
- Entered definitive agreement on Aug 3, 2026 to merge with Curium for $102.50/share at closing plus up to $12.00/share in CVRs, total value up to ~$8.0B
- Suspended previously issued FY2026 guidance due to pending transaction
- Cash and cash equivalents of $593.3M at June 30, 2026, up from $359.1M at Dec 31, 2025
Financial Impact
Acquisition consideration of up to $114.50/share, representing a total transaction value of up to approximately $8.0 billion
Risk Factors
- Transaction fails to close due to regulatory or stockholder approval issues
- CVR milestones may not be achieved, limiting total consideration to $102.50/share
- PYLARIFY revenue continues to decline, potentially impacting CVR value
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-336771 |
| Document: lnth-20260806.htm | 0001193125-26-336771 |
| Document: 0001193125-26-336771-index-headers.html | 0001193125-26-336771 |
| Document: 0001193125-26-336771-index.html | 0001193125-26-336771 |
| Document: 0001193125-26-336771.txt | 0001193125-26-336771 |
| 8-K Data (Synthetic) | 0001193125-26-336771 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $100.10 $99.80 | ▼ −0.30% | ▲ +0.22% | $100.10 (−0.00%) |
Oct 2, 2026 24d ago | DEFA14A | $100.19 $99.95 | ▼ −0.24% | ▼ −0.79% | $100.10 (−0.09%) |
Oct 2, 2026 24d ago | 8-K | $100.19 $99.95 | ▼ −0.24% | ▼ −0.79% | $100.10 (−0.09%) |
Sep 16, 2026 5w ago | DEFA14A | $100.80 $100.55 | ▼ −0.25% | ▼ −0.38% | $100.10 (−0.70%) |
Aug 26, 2026 8w ago | PREM14A | $100.82 $100.47 | ▼ −0.35% | ▼ −1.00% | $100.10 (−0.72%) |
Aug 14, 2026 10w ago | Press Release | $100.95 $100.91 | ▼ −0.04% | ▲ +0.43% | $100.10 (−0.85%) |
Aug 6, 2026 11w ago | 8-K | $101.07 $100.95 | ▼ −0.12% | ▼ −0.73% | $100.10 (−0.96%) |
Aug 3, 2026 12w ago | 8-K / DEFA14A | $101.11 $101.50 | ▲ +0.39% | ▲ +0.59% | $100.10 (−1.00%) |
Aug 3, 2026 12w ago | DEFA14A / 8-K | $101.19 $101.11 | ▼ −0.08% | ▼ −1.88% | $100.10 (−1.08%) |
Aug 3, 2026 12w ago | Press Release | $101.19 $101.11 | ▼ −0.08% | ▼ −1.88% | $100.10 (−1.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers